Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, shared a post on X:
“Last GI debate of the day with Dr. Olatunji Alese with James J. Harding re: choice of Immunotherapy in HCC.
Best part about in person meetings is meeting new friends.”
More posts featuring C. Eng.